Giles F - Search Results

1

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia.

Kreitman RJ, Dearden C, Zinzani PL, Delgado J, Karlin L, Robak T, Gladstone DE, le Coutre P, Dietrich S, Gotic M, Larratt L, Offner F, Schiller G, Swords R, Bacon L, Bocchia M, Bouabdallah K, Breems DA, Cortelezzi A, Dinner S, Doubek M, Gjertsen BT, Gobbi M, Hellmann A, Lepretre S, Maloisel F, Ravandi F, Rousselot P, Rummel M, Siddiqi T, Tadmor T, Troussard X, Yi CA, Saglio G, Roboz GJ, Balic K, Standifer N, He P, Marshall S, Wilson W, Pastan I, Yao NS, Giles F. Kreitman RJ, et al. Among authors: giles f. Leukemia. 2018 Aug;32(8):1768-1777. doi: 10.1038/s41375-018-0210-1. Epub 2018 Jul 20. Leukemia. 2018. PMID: 30030507 Free PMC article.

2

Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Beran M, Estey E, O'Brien SM, Giles FJ, Koller CA, Kornblau S, Keating M, Kantarjian HM. Beran M, et al. Among authors: giles fj. Leuk Lymphoma. 1998 Nov;31(5-6):521-31. doi: 10.3109/10428199809057611. Leuk Lymphoma. 1998. PMID: 9922042 Clinical Trial.

3

Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy.

Thomas DA, Kantarjian H, Smith TL, Koller C, Cortes J, O'Brien S, Giles FJ, Gajewski J, Pierce S, Keating MJ. Thomas DA, et al. Among authors: giles fj. Cancer. 1999 Oct 1;86(7):1216-30. doi: 10.1002/(sici)1097-0142(19991001)86:7<1216::aid-cncr17>3.0.co;2-o. Cancer. 1999. PMID: 10506707 Clinical Trial.

4

Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.

Sacchi S, Kantarjian HM, Freireich EJ, O'Brien S, Cortes J, Rios MB, Kornblau S, Giles FJ, Koller C, Gajewski J, Talpaz M. Sacchi S, et al. Among authors: giles fj. Leuk Lymphoma. 1999 Nov;35(5-6):483-9. doi: 10.1080/10428199909169612. Leuk Lymphoma. 1999. PMID: 10609785 Clinical Trial.

5

Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: a phase II study.

Giles FJ, O'Brien SM, Santini V, Gandhi V, Plunkett W, Seymour JF, Robertson LE, Kantarjian HM, Keating MJ. Giles FJ, et al. Leuk Lymphoma. 1999 Dec;36(1-2):57-65. doi: 10.3109/10428199909145949. Leuk Lymphoma. 1999. PMID: 10613450 Clinical Trial.

6

Oral idarubicin in patients with late chronic phase chronic myelogenous leukemia or chronic myelomonocytic leukemia.

Giles FJ, Wong GC, Clark SJ, Pierce S, Kantarjian HM, Keating MJ. Giles FJ, et al. Leuk Lymphoma. 2000 Mar;37(1-2):87-95. doi: 10.3109/10428190009057631. Leuk Lymphoma. 2000. PMID: 10721772 Clinical Trial.

7

A prospective randomized study of alpha-2b interferon plus hydroxyurea or cytarabine for patients with early chronic phase chronic myelogenous leukemia: the International Oncology Study Group CML1 study.

Giles FJ, Shan J, Chen S, Advani SH, Supandiman I, Aziz Z, Caviles AP, Tee GY, Chasen MR, Fahed Z, Chaoj TY, Aydogdu I, Lynott AM. Giles FJ, et al. Leuk Lymphoma. 2000 Apr;37(3-4):367-77. doi: 10.3109/10428190009089437. Leuk Lymphoma. 2000. PMID: 10752988 Clinical Trial.

8

Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase.

Giles FJ, Kantarjian H, O'Brien S, Rios MB, Cortes J, Beran M, Koller C, Keating M, Talpaz M. Giles FJ, et al. Leuk Lymphoma. 2001 Apr;41(3-4):309-19. doi: 10.3109/10428190109057985. Leuk Lymphoma. 2001. PMID: 11378543 Clinical Trial.

9

Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.

Verstovsek S, Kantarjian H, Estey E, Aguayo A, Giles FJ, Manshouri T, Koller C, Estrov Z, Freireich E, Keating M, Albitar M. Verstovsek S, et al. Among authors: giles fj. Leukemia. 2001 Aug;15(8):1165-70. doi: 10.1038/sj.leu.2402182. Leukemia. 2001. PMID: 11480557

10

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.

Dabaja BS, O'Brien SM, Kantarjian HM, Cortes JE, Thomas DA, Albitar M, Schlette ES, Faderl S, Sarris A, Keating MJ, Giles FJ. Dabaja BS, et al. Among authors: giles fj. Leuk Lymphoma. 2001 Jul;42(3):329-37. doi: 10.3109/10428190109064589. Leuk Lymphoma. 2001. PMID: 11699397 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

714 results

Search Page

Filters